About this trial
The goal of this clinical trial is to compare the effect of perioperative immunonutrition supplement in gynecologic cancer patients. The main questions it aims to answer are:
* is there any difference in the nutritional outcomes and functional outcomes between intervention and conventional groups? * is there any difference in the post-surgical outcomes between intervention and conventional groups?
Participants (intervention) will be provided the immunonutrition supplement before and after operation.
Researchers will compare intervention group with conventional group to see if there is any difference in postoperative outcomes.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Those who diagnosed with GC
Candidates for elective operation treatments
Disqualifiers
Those are involved gastrointestinal tract (complication)
Those are diagnosed with GC (metastasis)
Allergy to milk/soy/whey protein
Participate in other intervention study
Trial design
Parallel
Treatments tested in this trial
Immunonutrition oral nutrition supplementation
Dietary supplementParticipant will prescribed with 2 servings of immunonutrition supplement 5 days before surgery and 7 days after surgery
Treatment groups
Trial outcomes
Primary outcomes
daily energy and protein intake
24-hours diet recall
body composition
body composition analyzer; weight in kg; fat free mass in kg; fat mass in kg; muscle mass in kg; height in meter
immunoglobulin level
Concentration of immunoglobulin G; Concentration of immunoglobulin A; Concentration of immunoglobulin M
C-reactive protein
Concentration of C-reactive protein
Secondary outcomes
Functional status
handgrip strength in kg via Jammar dynamometer
stress level
questionnaire 10-item perceived stress scale (PSS-10) form
Sponsors and contacts
Click on the lead sponsor to view all of their trials.